| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |